Lv6
1760 积分 2022-12-13 加入
Discovery of Highly Potent and Selective, Orally Bioavailable BTK-Targeting PROTACs Featuring Novel CRBN-Binding Warheads
1天前
待确认
Catalytic Asymmetric Metallocyclopropanation Reactions Using Chloroform as a Carbyne Equivalent
1天前
待确认
Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation
9天前
已完结
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
9天前
已完结
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
9天前
已完结
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
9天前
已完结
Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
10天前
已关闭
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
10天前
已完结
Identification of N‑Methyl Nicotinamide and N‑Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)
10天前
已完结
Allosteric inhibitors of Bcr-abl–dependent cell proliferation
10天前
已完结
皖公网安备34019202002308
